| 1 |
14999778 | Immunohistochemical analysis of NAD(P)H:quinone oxidoreductase and NADPH cytochrome P450 reductase in human superficial bladder tumours: relationship between tumour enzymology and clinical outcome following intravesical mitomycin C therapy. | 2004 May 1 |
2 |
| 2 |
11600935 | Immunohistochemical localization of NAD(P)H:quinone oxidoreductase in conjunctival melanomas and primary acquired melanosis. | 2001 May |
1 |
| 3 |
11709197 | Genotyping of NAD(P)H:quinone oxidoreductase (NQO1) in a panel of human tumor xenografts: relationship between genotype status, NQO1 activity and the response of xenografts to Mitomycin C chemotherapy in vivo(1). | 2001 Nov 15 |
2 |
| 4 |
9232934 | Tumor-specific synergistic therapy of mitomycin C: modulation of bioreductive activation. | 1997 Jun |
1 |
| 5 |
8912865 | The NAD(P)H:quinone oxidoreductase locus in human colon carcinoma HCT 116 cells resistant to mitomycin C. | 1996 Nov 15 |
3 |
| 6 |
7812966 | NAD(P)H:quinone oxidoreductase expression and mitomycin C resistance developed by human colon cancer HCT 116 cells. | 1995 Jan 15 |
3 |
| 7 |
7857313 | Involvement of NF-kappa B in the induction of NAD(P)H:quinone oxidoreductase (DT-diaphorase) by hypoxia, oltipraz and mitomycin C. | 1995 Jan 31 |
1 |
| 8 |
8567314 | DT-diaphorase as a target enzyme for biochemical modulation of mitomycin C. | 1995 Sep |
2 |
| 9 |
7945992 | Loss of heterozygosity at the NAD(P)H: quinone oxidoreductase locus associated with increased resistance against mitomycin C in a human bladder carcinoma cell line. | 1994 Jul |
1 |
| 10 |
7685584 | [Mitomycin C and its bioreduction: relevance of NAD(P)H: quinone oxidoreductase activity to mitomycin C-induced DNA damage and cytotoxicity]. | 1993 Jun |
3 |